Fig. 1From: Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeuticsOverview of hepatic triglycerides metabolism. TG, triglycerides; SREBP, sterol regulatory element–binding protein; ChREBP, carbohydrate response element binding protein; FFA, free fatty acid; IR, insulin resistance; CD36, cluster of differentiation 36; FATP, fatty acid transport proteins; VLDL, very-low density lipoprotein; MTTP, Microsomal TG transfer protein; FAO, fatty acid β-oxidation; CPT, carnitine palmitoyl transferase; DNL, de novo lipogenesisBack to article page